JAK Inhibitor News and Research

RSS
New data demonstrating the strength of Novartis' hematology portfolio to be presented

New data demonstrating the strength of Novartis' hematology portfolio to be presented

Incyte enters into collaboration and license agreement with Novartis

Incyte enters into collaboration and license agreement with Novartis

TNF-alpha inhibitors and interleukin inhibitors to drive psoriasis drug market

TNF-alpha inhibitors and interleukin inhibitors to drive psoriasis drug market

Clinical trial results of topical INCB18424 inhibitor announced by Incyte Corporation

Clinical trial results of topical INCB18424 inhibitor announced by Incyte Corporation

Discovery of mutant genes in acute lymphoblastic leukemia

Discovery of mutant genes in acute lymphoblastic leukemia

Incyte's selective Janus kinase inhibitor demonstrates rapid and durable clinical benefits in Myelofibrosis patients

Incyte's selective Janus kinase inhibitor demonstrates rapid and durable clinical benefits in Myelofibrosis patients